Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 215.00
+0.50 (0.23%)
Jun 16, 2026, 4:35 PM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 465.31 million as of June 16, 2026. Its market cap has increased by 2.72% in one year.
Market Cap
465.31M
Enterprise Value
530.13M
Revenue
228.94M
Ranking
n/a
PE Ratio
47.57
Stock Price
215.00
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 465.31M, an increase of 4,089.34%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 465.31M | -1.04% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 204.73B |
| GSK plc | 78.16B |
| Haleon | 29.69B |
| Smith & Nephew | 9.60B |
| Spire Healthcare Group | 867.29M |
| CVS Group | 852.40M |
| Oxford Biomedica | 730.36M |
| Allergy Therapeutics | 500.27M |